Bioorganic and Medicinal Chemistry Letters p. 339 - 344 (1996)
Update date:2022-08-03
Topics:
Xue
Rafalski
Roderick
Eyermann
Mousa
Olson
DeGrado
A potent centrally constrained series of benzimidazole and benzoxazole glycoprotein IIb/IIIa inhibitors has been discovered based on the solution conformation of a cyclic RGD-containing peptide, DMP 728. The high potency of this series of compounds in the inhibition of platelet aggregation requires a benzamidine as the basic moiety and an α-carbamate or sulfonamide substituted β-alanine as the acidic moiety.
View MoreYurui(Shanghai)Chemical Co.,Ltd
Contact:0086 21-50456736
Address:No.3188 Xiupu Road,Shanghai
Contact:21-7631221 15884421033
Address:326 Science and technology,Shanghai,China
GUANGZHOU MEDCAN PHARMATECH LTD
website:http://www.gzmedcan.com
Contact:+86-20-82519649
Address:Building J,Room 101,1 JiangtashanRd,Guang Zhou Science City,Guang Zhou ,China
Contact:021-50278900
Address:No.6,Room 201 ,Lane 299,bisheng road ,shanghai ,china
Quzhou Ruiyuan chemical Co., Ltd
Contact:+86-570-3039321/3039361/3039308
Address:18# Huayang Road,Quzhou High-tech Industrial Park, Zhejiang China.
Doi:10.1016/0020-1693(95)90040-D
(1995)Doi:10.1023/A:1015054907007
(2002)Doi:10.1021/jo960008k
(1996)Doi:10.1023/A:1012374828303
(2001)Doi:10.1021/ic951550e
(1996)Doi:10.1016/0022-328X(95)05885-S
(1996)